Lexicon Pharmaceuticals
LXRX
#6861
Rank
S$0.87 B
Marketcap
S$1.98
Share price
-8.38%
Change (1 day)
4.24%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): S-$0.18

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.18. In 2025 the company made an earnings per share (EPS) of S-$0.18 an increase over its 2024 EPS that were of S-$0.83.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.18-0.3%
2025S-$0.18-78.13%
2024S-$0.83-20%
2023S-$1.0331.15%
2022S-$0.79-0%
2021S-$0.7910.91%
2020S-$0.71-145.08%
2019S$1.58-206.09%
2018S-$1.49-5.74%
2017S-$1.58-10.95%
2016S-$1.772640%
2015S-$0.06458-96.34%
2014S-$1.76-2.53%
2013S-$1.81-9.09%
2012S-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$24.53-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.61-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$60.68-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$6.70 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.35-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02583-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.97 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S-$0.12-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$37.83 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA